Nicole Campbell

Sarah McLean

Assistant Professor
BMSUE IMS Developer

PH.D. University of Guelph 
B.Sc. University of Guelph 
Office:  Medical Sciences Building 204
p. 519.661.2111 x. 82773
f. 519.661.3827 
e. nicole.campbell@schulich.uwo.ca


Dr. Nicole Campbell received her undergraduate and graduate degrees from the University of Guelph in Biomedical Sciences.  Throughout her graduate studies, Dr. Campbell obtained numerous teaching experiences, including distance education instruction, course development and course coordination.  After completing her PhD, Dr. Campbell worked as an instructor at various institutions teaching courses in physiology, pharmacology, pathophysiology and research methodology.  Dr. Campbell will be responsible for the Year 4 Medical Science courses and the co-development and teaching of a Year 3 interdisciplinary lab course for students in the Honors Specialization Interdisciplinary Medical Sciences (IMS).

Publications:

Campbell NE, Greenaway J, Henkin J and Petrik J 2011. “ABT-898 induces tumor regression and prolongs survival in a mouse model of epithelial ovarian cancer.” [Mol Cancer Ther. 2011 Oct;10(10):1876-85]

Campbell NE, Kellenberger LD , Greenaway J, Moorehead RA, Linnerth-Petrik NM, Petrik J. 2010. “Extracellular matrix proteins and tumor angiogenesis.” [J Oncol. 2010;2010:586905]

Campbell NE, Greenaway J, Henkin J and Petrik J 2010. “The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer.” [Neoplasia. Mar;12(3):275-83]

Kellenberger LD, Bruin JE, Greenaway J, Campbell NE, Moorehead RA, Holloway AC and Petrik J 2010. “The role of dysregulated glucose metabolism in epithelial ovarian cancer.” [J. Oncol. 2010;2010:514310]

Solinger N and Sonea IM 2008. “Distribution of neurokinin-1 receptor in equine intestinal smooth muscle.” [Equine Vet J. 2008 Jun;40(4):321-5]